Athersys Inc (ATHXQ)

[JLuce888]

Here's my 2nd post. I have read almost all the published scientific research on Multistem. It is pretty solid. The company leadership chose wisely in which clinical studies to pursue. The ulcerative colitis study involves a condition where there is no good treatment at present, and effectivity of treatment can be easily demonstrated. The ischemic stroke study involves a disease that costs a lot if untreated, both economically and emotionally. A small percentage of patients get tPA treatment because of the limited window to give it. Multistem can expand that window and treat many more potential patients. If either one, or both studies, show Multistem to be effective, it will be a big help to a lot of people, and profitable for ATHX.